Ezetimibe/Simvastatin Teva Pharma 10 mg/40 mg tablets

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Ezetimibe; Simvastatin

Available from:

Teva B.V.

ATC code:

C10BA; C10BA02

INN (International Name):

Ezetimibe; Simvastatin

Dosage:

10 mg/40 milligram(s)

Pharmaceutical form:

Tablet

Prescription type:

Product subject to prescription which may be renewed (B)

Therapeutic area:

HMG CoA reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe

Authorization status:

Marketed

Authorization date:

2016-12-16

Patient Information leaflet

PACKAGE LEAFLET
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
EZETIMIBE/SIMVASTATIN TEVA PHARMA 10 MG/20 MG TABLETS
EZETIMIBE/SIMVASTATIN TEVA PHARMA 10 MG/40 MG TABLETS
EZETIMIBE/SIMVASTATIN TEVA PHARMA 10 MG/80 MG TABLETS
ezetimibe/simvastatin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Ezetimibe/Simvastatin Teva
Pharma is and what it is used for
2.
What you need to know before you take Ezetimibe/Simvastatin Teva
Pharma
3.
How to take Ezetimibe/Simvastatin Teva Pharma
4.
Possible side effects
5.
How to store Ezetimibe/Simvastatin Teva Pharma
6.
Contents of the pack and other information
1.
WHAT EZETIMIBE/SIMVASTATIN TEVA PHARMA IS AND WHAT IT IS USED FOR
Ezetimibe/Simvastatin Teva Pharma contains the active substances
ezetimibe and simvastatin.
Ezetimibe/Simvastatin Teva
Pharma is a medicine used to lower levels of total cholesterol,
“bad”
cholesterol (LDL cholesterol), and fatty substances called
triglycerides in the blood. In addition,
Ezetimibe/Simvastatin Teva
Pharma raises levels of “good” cholesterol (HDL cholesterol).
Ezetimibe/Simvastatin Teva Pharma works to reduce your cholesterol in
two ways. The active
ingredient ezetimibe reduces the cholesterol absorbed in your
digestive tract. The active ingredient
simvastatin belonging to the class of “statins” inhibits the
production of the cholesterol your body
makes by itself.
Cholesterol is one of several fatty substances found in the
bloodstream. Your total cholesterol is made
up mainly of LDL and HDL cholesterol.
LDL choles

Summary of Product characteristics

Health Products Regulatory Authority
18 May 2023
CRN00DGHL
Page 1 of 25
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Ezetimibe/Simvastatin Teva Pharma 10 mg/40 mg tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 10 mg ezetimibe and 40 mg simvastatin.
Excipient with known effect:
Each 10 mg/40 mg tablet contains 236.52mg of lactose monohydrate
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
Ezetimibe/Simvastatin Actavis 10 mg/40 mg tablets: Light tan, mottled,
round, 10 mm in diameter, biconvex tablets, plain on
one side and “513” on the other side.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Prevention of Cardiovascular Events
Ezetimibe/Simvastatin Teva Pharma is indicated to reduce the risk of
cardiovascular events (see section 5.1) in patients with
coronary heart disease (CHD) and a history of acute coronary syndrome
(ACS), either previously treated with a statin or not.
Hypercholesterolaemia
Ezetimibe/Simvastatin Teva Pharma is indicated as adjunctive therapy
to diet for use in patients with primary (heterozygous
familial and non-familial) hypercholesterolaemia or mixed
hyperlipidaemia where use of a combination product is appropriate:

patients not appropriately controlled with a statin alone

patients already treated with a statin and ezetimibe
Homozygous Familial Hypercholesterolaemia (HoFH)
Ezetimibe/Simvastatin Teva Pharma is indicated as adjunctive therapy
to diet for use in patients with HoFH. Patients may also
receive adjunctive treatments (e.g., low-density lipoprotein [LDL]
apheresis).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Hypercholesterolaemia_
The patient should be on an appropriate lipid-lowering diet and should
continue on this diet during treatment with
Ezetimibe/Simvastatin Teva Pharma.
Route of administration is oral. The dosage range of
Ezetimibe/Simvastatin Teva Pharma is 10 mg/10 mg/day through
10 mg/80 mg/day in the evening. All dosages may not be available in
all member states. The